LOMUSTINE , Odomzo 200 mg hard capsules, VINCRISTINE, CISPLATIN
1634
Phase 2 small_molecule active
Quick answer
LOMUSTINE , Odomzo 200 mg hard capsules, VINCRISTINE, CISPLATIN for Newly Diagnosed Medulloblastoma is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Newly Diagnosed Medulloblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active